Impact of concurrent antibody–drug conjugates and radiotherapy on symptomatic radiation necrosis in breast cancer patients with brain metastases: a multicenter retrospective study
Yutaro Koide(Nagoya University Hospital), Takeshi Kodaira(Aichi Cancer Center), Mariko Kawamura(Nagoya University), Sou Adachi(Aichi Medical University Hospital), Takahiro Aoyama(Aichi Cancer Center), Masayuki Itô(Fujita Health University), Shingo Hashimoto(Aichi Cancer Center), Makoto Ito(Fujita Health University), Hiroyuki Tachibana(Aichi Cancer Center), Yurika Shindo(Aichi Cancer Center), Hidetoshi Shimizu(Aichi Cancer Center), Fumitaka Ito(Fujita Health University), Naoya Nagai(Aichi Cancer Center)
Cited by 34
Related Papers
Role of high-dose salvage radiotherapy for oligometastases of the localised abdominal/pelvic lymph nodes: a retrospective study
|BMC Cancer|2020|27
Risk of second primary malignancies after definitive treatment for esophageal cancer: A competing risk analysis
|Cancer Medicine|2019|23
A predictive model for pain response following radiotherapy for treatment of spinal metastases
|Scientific Reports|2021|23
Comparison of atlas-based auto-segmentation accuracy for radiotherapy in prostate cancer
|Physics and Imaging in Radiation Oncology|2021|17